SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-008970
Filing Date
2024-03-22
Accepted
2024-03-22 17:00:15
Documents
1
Period of Report
2024-03-20

Document Format Files

Seq Description Document Type Size
1 form4-03222024_050301.html 4  
1 form4-03222024_050301.xml 4 3691
  Complete submission text file 0001415889-24-008970.txt   5072
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
Donoghoe Nicholas (Reporting) CIK: 0001762951 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35565 | Film No.: 24776044